Your browser doesn't support javascript.
loading
Evolution of electroencephalogram in infants with tuberous sclerosis complex and neurodevelopmental outcome: a prospective cohort study.
De Ridder, Jessie; Kotulska, Katarzyna; Curatolo, Paolo; Jansen, Anna C; Aronica, Eleonora; Kwiatkowski, David J; Jansen, Floor E; Józwiak, Sergiusz; Lagae, Lieven.
Afiliação
  • De Ridder J; Department of Development and Regeneration, Section Pediatric Neurology, Catholic University of Leuven (KU Leuven), Leuven, Belgium.
  • Kotulska K; Department of Neurology and Epileptology, The Children's Memorial Health Institute, Warsaw, Poland.
  • Curatolo P; Child Neurology and Psychiatry Unit, Systems Medicine Department, Tor Vergata University, Rome, Italy.
  • Jansen AC; Pediatric Neurology Unit, University Hospital Brussel, Brussels, Belgium.
  • Aronica E; Department of (Neuro) Pathology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • Kwiatkowski DJ; Stichting Epilepsie Instellingen Nederland, Heemstede, the Netherlands.
  • Jansen FE; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Józwiak S; Department of Child Neurology, Brain Centre, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Lagae L; Department of Neurology and Epileptology, The Children's Memorial Health Institute, Warsaw, Poland.
Dev Med Child Neurol ; 64(4): 495-501, 2022 04.
Article em En | MEDLINE | ID: mdl-34601720
AIM: To describe the evolution of electroencephalogram (EEG) characteristics in infants with tuberous sclerosis complex (TSC) and the relationship with neurodevelopmental outcome at 24 months. METHOD: Eighty-three infants were enrolled in the EPISTOP trial and underwent serial EEG follow-up until the age of 24 months (males n=45, females n=37, median age at enrolment 28d, interquartile range 14-54d). Maturation of the EEG background and epileptiform discharges were compared between the TSC1 and TSC2 variants and between preventive and conventional groups respectively. RESULTS: Children with TSC2 more frequently had a slower posterior dominant rhythm (PDR) at 24 months (51% vs 11%, p=0.002), a higher number of epileptiform foci (median=8 vs 4, p=0.003), and a lower fraction of EEGs without epileptiform discharges (18% vs 61%, p=0.001) at follow-up. A slower PDR at 24 months was significantly associated with lower cognitive (median=70 vs 80, p=0.028) and motor developmental quotients (median=70 vs 79, p=0.008). A higher fraction of EEGs without epileptiform discharges was associated with a lower probability of autism spectrum disorder symptoms (odds ratio=0.092, 95% confidence interval=0.009-0.912, p=0.042) and higher cognitive (p=0.004), language (p=0.002), and motor (p=0.001) developmental quotients at 24 months. INTERPRETATION: TSC2 is associated with more abnormal EEG characteristics compared to TSC1, which are predictive for neurodevelopmental outcome.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Tuberosa / Transtorno do Espectro Autista Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Tuberosa / Transtorno do Espectro Autista Idioma: En Ano de publicação: 2022 Tipo de documento: Article